Article Type
Article
Changed
Thu, 03/31/2022 - 12:18
Display Headline
Cancer Data Trends 2022: Gastrointestinal Cancers

Click to view more from Cancer Data Trends 2022.

References

  1. Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432-443. doi: 10.1038/s41575-021-00419-3 

  1. Fitzgerald RC, di Pietro M, O'Donovan M, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396(10247):333-344. doi:10.1016/S0140-6736(20)31099-0 

  1. Krishna Chandar A, Sharma A, Chak A. Novel screening alternatives for Barrett esophagus. Gastroenterol Hepatol (NY). 2020;16(5):238-245. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132638/  

  1. Centers for Disease Control and Prevention. Colorectal cancer awareness. Updated February 23, 2021. Accessed December 14, 2021. https://www.cdc.gov/cancer/dcpc/resources/features/colorectalawareness/index.htm  

  1. US Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening. Published May 18, 2021. Accessed January 27, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening 

  1. Imperiale TF, Daggy JK, Imler TM, et al. Prevalence of advanced colorectal neoplasia in veterans: effects of age, sex, and race/ethnicity. J Clin Gastroenterol. 2021;55(10):876-883. doi:10.1097/MCG.0000000000001402 

  1. Demb J, Yaseyyedi A, Liu L, et al. Metformin is associated with reduced odds for colorectal cancer among persons with diabetes. Clin Transl Gastroenterol. 2019;10(11):e00092. doi:10.14309/ctg.0000000000000092  

  1. Beste LA, Green P, Berry K, et al. Hepatitis C-related hepatocellular carcinoma incidence in the Veterans Health Administration after introduction of direct-acting antivirals. JAMA. 2020;324(10):1003-1005. doi:10.1001/jama.2020.10121 

  1. Kanwal F, Kramer JR, Asch SM, et al. Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents. Hepatology. 2020;71(1):44-55. doi:10.1002/hep.30823 

  1. Ayyagari S, Tan MC, Liu Y, et al. Use of acid-suppressant medications after diagnosis increases mortality in a subset of gastrointestinal cancer patients. Dig Dis Sci. 2020;65(9):2691-2699. doi:10.1007/s10620-019-05984-x 

Publications
Federal Practitioner

Click to view more from Cancer Data Trends 2022.

Click to view more from Cancer Data Trends 2022.

References

  1. Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432-443. doi: 10.1038/s41575-021-00419-3 

  1. Fitzgerald RC, di Pietro M, O'Donovan M, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396(10247):333-344. doi:10.1016/S0140-6736(20)31099-0 

  1. Krishna Chandar A, Sharma A, Chak A. Novel screening alternatives for Barrett esophagus. Gastroenterol Hepatol (NY). 2020;16(5):238-245. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132638/  

  1. Centers for Disease Control and Prevention. Colorectal cancer awareness. Updated February 23, 2021. Accessed December 14, 2021. https://www.cdc.gov/cancer/dcpc/resources/features/colorectalawareness/index.htm  

  1. US Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening. Published May 18, 2021. Accessed January 27, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening 

  1. Imperiale TF, Daggy JK, Imler TM, et al. Prevalence of advanced colorectal neoplasia in veterans: effects of age, sex, and race/ethnicity. J Clin Gastroenterol. 2021;55(10):876-883. doi:10.1097/MCG.0000000000001402 

  1. Demb J, Yaseyyedi A, Liu L, et al. Metformin is associated with reduced odds for colorectal cancer among persons with diabetes. Clin Transl Gastroenterol. 2019;10(11):e00092. doi:10.14309/ctg.0000000000000092  

  1. Beste LA, Green P, Berry K, et al. Hepatitis C-related hepatocellular carcinoma incidence in the Veterans Health Administration after introduction of direct-acting antivirals. JAMA. 2020;324(10):1003-1005. doi:10.1001/jama.2020.10121 

  1. Kanwal F, Kramer JR, Asch SM, et al. Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents. Hepatology. 2020;71(1):44-55. doi:10.1002/hep.30823 

  1. Ayyagari S, Tan MC, Liu Y, et al. Use of acid-suppressant medications after diagnosis increases mortality in a subset of gastrointestinal cancer patients. Dig Dis Sci. 2020;65(9):2691-2699. doi:10.1007/s10620-019-05984-x 

References

  1. Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432-443. doi: 10.1038/s41575-021-00419-3 

  1. Fitzgerald RC, di Pietro M, O'Donovan M, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396(10247):333-344. doi:10.1016/S0140-6736(20)31099-0 

  1. Krishna Chandar A, Sharma A, Chak A. Novel screening alternatives for Barrett esophagus. Gastroenterol Hepatol (NY). 2020;16(5):238-245. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132638/  

  1. Centers for Disease Control and Prevention. Colorectal cancer awareness. Updated February 23, 2021. Accessed December 14, 2021. https://www.cdc.gov/cancer/dcpc/resources/features/colorectalawareness/index.htm  

  1. US Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening. Published May 18, 2021. Accessed January 27, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening 

  1. Imperiale TF, Daggy JK, Imler TM, et al. Prevalence of advanced colorectal neoplasia in veterans: effects of age, sex, and race/ethnicity. J Clin Gastroenterol. 2021;55(10):876-883. doi:10.1097/MCG.0000000000001402 

  1. Demb J, Yaseyyedi A, Liu L, et al. Metformin is associated with reduced odds for colorectal cancer among persons with diabetes. Clin Transl Gastroenterol. 2019;10(11):e00092. doi:10.14309/ctg.0000000000000092  

  1. Beste LA, Green P, Berry K, et al. Hepatitis C-related hepatocellular carcinoma incidence in the Veterans Health Administration after introduction of direct-acting antivirals. JAMA. 2020;324(10):1003-1005. doi:10.1001/jama.2020.10121 

  1. Kanwal F, Kramer JR, Asch SM, et al. Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents. Hepatology. 2020;71(1):44-55. doi:10.1002/hep.30823 

  1. Ayyagari S, Tan MC, Liu Y, et al. Use of acid-suppressant medications after diagnosis increases mortality in a subset of gastrointestinal cancer patients. Dig Dis Sci. 2020;65(9):2691-2699. doi:10.1007/s10620-019-05984-x 

Publications
Federal Practitioner
Publications
Federal Practitioner
Article Type
Article
Display Headline
Cancer Data Trends 2022: Gastrointestinal Cancers
Display Headline
Cancer Data Trends 2022: Gastrointestinal Cancers
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 03/14/2022 - 12:30
Un-Gate On Date
Mon, 03/14/2022 - 12:30
Use ProPublica
CFC Schedule Remove Status
Mon, 03/14/2022 - 12:30
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media